Blockchain for PHARMA Scientists & Engineers
  • What is Blockchain BioPharma?
    • Blockchain BioPharma: R&D Origins
      • Harvard Business Review: Why Big Pharma Is Betting on Blockchain
    • 2022 DEV OPS ROADMAP
    • WEDNESDAY, MARCH 16,2022 SPRINT 0: DEMO VIDEO
    • PHARMA INDUSTRY SOLUTIONS: The 80/20 Non-Profit Pharma Company
    • Our Calling for a Pharmaceutical Coalition
    • BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA
    • $20(M-USD) Is The Important Number - As of Now We Have 200 Million ERC & BEP PHARMA Tokens.
    • DAO Mission & Vison
      • Where Will Pharmaceutical eNFT's Come From?
    • Information Architecture Diagram
      • WARNING! ALT-COINS GLOBALLY TARGETED - NEED FOR DEVSECOPS
    • Blockchain BioPharma GAP Analysis
    • Blockchain BioPharma Tokenomics
      • PROPOSED GLOBAL CENTRAL BANK CBDC INTEGRATIONS
      • INTEGRATION POINTS FOR SWIFT & CBDC's
    • BANKING-GRADE SECURITY: SWIFT CODE INTEGRATION
    • Sales & Revenue Model
      • PRODUCT: Quantum SSO
      • PRODUCT: Metaverse Software Apps
      • PRODUCT: eNFT Marketplace for Medicines (Polygon)
        • TYPES OF ENTERPRISE PHARMA eNFT’s:
      • PRODUCT: Metaverse of PHARMA - Introducing CloudLab (VR/AR)
      • SERVICE: Metaverse Development MSP
        • Blockchain BioPharma: MSP Services Rate Card
      • SERVICE: Private-Label IP Monetization (HyperLedger)
      • SERVICE: ENTERPRISE BLOCKCHAIN SMART CONTRACT GAS-FEES
    • What is the Pharmaceutical Token (Ticker: PHARMA)?
      • Are PHARMA Tokens Regulated?
      • Legal Position on the Pharmaceutical Token
      • Using Ethereum Blockchain for Pharmacogenomics Smart Contracts
    • Where Can You Download The Blockchain BioPharma Desktop Applications?
    • What Industries Do We Target?
    • Are PHARMA Tokens on the Cryptocurrency Exchanges?
    • Who Uses The Blockchain BioPharma Application?
    • Does Blockchain BioPharma Loan Money to Drug Developers?
    • Desktop Software Demo
    • Enterprise Pharma eNFT Example
    • Artificial Intelligence & Machine Learning
    • STATE OF THE METAVERSE UNION - Metaverse Market Research
    • Q2 - 2022: Crowdsale
    • Smart Contract Types
    • Competitive Landscape
      • AGILE: Our Competitive Advantage
  • The Competition Justifies our Business Model
    • COMPETITOR #1: Molecule.to
    • COMPETITOR #2: Pharmalyse Finance
  • Get in Touch With Our Community
  • 100% Regulatory and Compliance Transparency
    • Crypto Accounting 101: Price Water House Coopers Regulatory Compliance Opinion
Powered by GitBook
On this page

Was this helpful?

The Competition Justifies our Business Model

Although we have the most unique enterprise model of its kind in the pharmaceutical space, after Blockchain BioPharma launched, two competitors did launch after, which we expected.

PreviousAGILE: Our Competitive AdvantageNextGet in Touch With Our Community

Last updated 2 years ago

Was this helpful?

  1. Molecule.to: Based in Germany and co-founded by former Linux executives, Molecule appears to have launched an NFT Marketplace already.

  2. Pharmalyse Finance: Appears to only have a Medium Site for now, and appears to be mainly R&D, just as Blockchain BioPharma was in the beginning.

COMPETITIVE ADVANTAGE

  1. Blockchain BioPharma has better branding

  2. Blockchain BioPharma has a more advanced architecture

  3. Blockchain BioPharma is a #Data Company First, DeFi is only a part of that data.

Blockchain BioPharma is the first PHARMA Company of its kind, and while we see competition brewing with the publication of our #Research, we also see this type of business as a "Blue Ocean" that can make more profits, if the global PHARMA companies work with us, should they decide to join forces on our platform. It may be hard, the Pharmaceutical industry is highly conservative, by design.